$354M exit package in hand, Medivation CEO David Hung completes a master class in biotech auctions
Now that Medivation CEO David Hung has completed the deal of a lifetime with a stratospheric buyout, he’s grabbing a $35 million golden parachute that is scheduled to burst open in about a month and carry him back down to earth in style. And that’s part of a $354 million package of stock and options he can now cash out of.
The details on the golden parachute — along with a blow-by-blow account of the bidding process that led up to Pfizer’s $14 billion winner — were all included in an SEC filing on Tuesday. And it makes for required reading for any biotech exec looking to make the big score some sunny day.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters